Your browser is no longer supported. Please, upgrade your browser.
Settings
LLY Eli Lilly and Company daily Stock Chart
LLY [NYSE]
Eli Lilly and Company
IndexS&P 500 P/E48.29 EPS (ttm)2.27 Insider Own11.30% Shs Outstand1.04B Perf Week0.08%
Market Cap114.14B Forward P/E18.95 EPS next Y5.79 Insider Trans-3.29% Shs Float1.04B Perf Month-1.10%
Income2.36B PEG3.91 EPS next Q1.35 Inst Own80.00% Short Float1.08% Perf Quarter5.22%
Sales24.28B P/S4.70 EPS this Y-37.00% Inst Trans-0.71% Short Ratio2.71 Perf Half Y34.47%
Book/sh12.82 P/B8.57 EPS next Y3.87% ROA1.00% Target Price113.00 Perf Year33.12%
Cash/sh8.69 P/C12.63 EPS next 5Y12.34% ROE3.50% 52W Range73.69 - 116.61 Perf YTD30.01%
Dividend2.25 P/FCF50.24 EPS past 5Y-15.00% ROI6.60% 52W High-5.83% Beta0.27
Dividend %2.05% Quick Ratio1.50 Sales past 5Y0.20% Gross Margin73.40% 52W Low49.02% ATR2.95
Employees40655 Current Ratio1.90 Sales Q/Q7.10% Oper. Margin12.30% RSI (14)50.46 Volatility2.27% 2.52%
OptionableYes Debt/Eq0.97 EPS Q/Q112.90% Profit Margin1.90% Rel Volume1.31 Prev Close112.39
ShortableYes LT Debt/Eq0.89 EarningsNov 06 BMO Payout492.40% Avg Volume4.12M Price109.81
Recom2.30 SMA200.09% SMA500.90% SMA20020.14% Volume5,387,732 Change-2.30%
Oct-31-18Upgrade Credit Suisse Underperform → Neutral
Oct-09-18Initiated Guggenheim Buy
Oct-01-18Reiterated SunTrust Buy $105 → $123
Sep-26-18Resumed JP Morgan Overweight $117
Jul-25-18Downgrade Berenberg Buy → Hold
Jun-08-18Initiated Cantor Fitzgerald Overweight $100
Apr-13-18Upgrade BMO Capital Markets Underperform → Market Perform $74 → $79
Jan-22-18Downgrade Credit Suisse Neutral → Underperform
Jan-16-18Downgrade Goldman Buy → Neutral
Jan-05-18Upgrade Argus Hold → Buy
Oct-10-17Downgrade Credit Suisse Outperform → Neutral
Jul-26-17Downgrade Leerink Partners Outperform → Mkt Perform
Apr-27-17Downgrade Argus Buy → Hold
Apr-17-17Downgrade Morgan Stanley Overweight → Equal-Weight
Apr-07-17Reiterated Barclays Overweight $85 → $90
Mar-20-17Reiterated UBS Neutral $70 → $85
Dec-16-16Upgrade Morgan Stanley Equal-Weight → Overweight
Sep-27-16Upgrade Goldman Neutral → Buy
Sep-08-16Upgrade JP Morgan Neutral → Overweight
May-02-16Reiterated Leerink Partners Outperform $96 → $101
Nov-14-18 04:06PM  Migraine-Focused Biotech Has A Headache On Quarterly Losses Investor's Business Daily
03:34PM  AbbVie's HCV Drug Mavyret Succeeds in Label Expansion Study Zacks
10:15AM  Merck Starts Rolling BLA Submission for Ebola Vaccine V920 Zacks
08:02AM  Shire's Filing Accepted by FDA for Gattex's Label Expansion Zacks
07:52AM  Eli Lilly announces progress on new headache medications MarketWatch
06:45AM  Lilly Submits New Drug Application to the FDA for Lasmiditan for Acute Treatment of Migraine, Receives Breakthrough Therapy Designation for Emgality (galcanezumab-gnlm) for Prevention of Episodic Cluster Headache PR Newswire
Nov-13-18 06:37PM  More and More Hedge Funds Are Selling Eli Lilly and Company (LLY) Insider Monkey
01:17PM  Bayer (BAYRY) Beats on Q3 Earnings, Revenue Estimates Zacks
07:00AM  Walmart, Home Depot adopt health insurer tactic in drug copay battle Reuters
Nov-12-18 05:50PM  Eli Lilly (LLY) Gains As Market Dips: What You Should Know Zacks
04:15PM  IBD Stock Of The Day Nears Buy Point As It Outperforms Big Pharma Rivals Investor's Business Daily
03:46PM  5 Stocks to Sell After the Midterm Election InvestorPlace
Nov-09-18 03:17PM  Catalyst (CPRX) Reports Q3 Loss as Expected & Pipeline Update Zacks
02:23PM  Keryx's (KERX) Loss Narrower Than Expected in Q3, Sales Lag Zacks
07:31AM  Pharma Stock Roundup: LLY, AZN Report Q3 Earnings, PFE Gets FDA Nod for Cancer Drug Zacks
Nov-08-18 04:30PM  Lilly to Participate in Credit Suisse 27th Annual Healthcare Conference PR Newswire
02:53PM  Novo Nordisk Continues Its Balancing Act Motley Fool
11:13AM  Horizon Pharma (HZNP) Q3 Earnings & Sales Beat, Shares Rise Zacks
10:43AM  Nektar (NKTR) Q3 Earnings & Sales Beat Estimates, Shares Up Zacks
Nov-07-18 04:53PM  Better Buy: Eli Lilly and Company vs. AbbVie Inc. Motley Fool
04:08PM  Mallinckrodt (MNK) Beats on Q3 Earnings Estimates, Ups View Zacks
12:22PM  Drug Stocks Climb as Investors Digest Midterm Election Results TheStreet.com
07:55AM  Edited Transcript of LLY earnings conference call or presentation 6-Nov-18 2:00pm GMT Thomson Reuters StreetEvents
Nov-06-18 06:21PM  Stocks - Dow Rallies as Midterm Mania Grips Wall Street Investing.com
05:38PM  Eli Lilly Shares Decline on Tuesday Despite Strong Earnings Release TheStreet.com
04:54PM  The midterm election could decide the fate of these three health-care groups CNBC
04:50PM  What Happened in the Stock Market Today Motley Fool
04:25PM  Nasdaq Gains for First Day in Three as U.S. Voters Head to the Polls TheStreet.com
04:12PM  Eli Lilly & Co (LLY) Q3 2018 Earnings Conference Call Transcript Motley Fool
03:40PM  MarketPulse: Mylan Surges to Keep Health Care Stocks Well Above Flatline Investing.com
03:15PM  Eli Lilly's Conservative Pricing Offers Protection From Political Pressure TheStreet.com
02:13PM  Eli Lilly's Elanco Offload Offers Acquisition Flexibility TheStreet.com
02:08PM  Buy Eli Lilly on the pullback? Why isn't Southwest taking... CNBC Videos
01:44PM  Will Stocks Gain After the Elections? & Earnings from CVS, LLY, HEAR Zacks
01:28PM  Eli Lilly Tops Q3 Earnings Estimate, Lifts 2018 Outlook as Diabetes Sales Rise TheStreet.com
12:51PM  Trulicity leads mixed third quarter for Lilly; shares sink Reuters
12:38PM  Eli Lillys Big Picture Justifies Its Lofty Valuation Bloomberg
12:18PM  Wall Street Continues to See Opportunity in Eli Lilly TheStreet.com
11:47AM  2 Groups to Watch as the Midterm Election Unfolds: Cannabis and Drug Stocks TheStreet.com
11:43AM  Stocks - Wall Street Rises After Upbeat Earnings Investing.com
11:22AM  Trulicity leads mixed third quarter for Lilly; shares sink Reuters
10:39AM  September JOLTS Report In Spotlight Zacks
10:28AM  Lilly (LLY) Tops Q3 Earnings, Lifts 2018 Outlook, Stock Up Zacks
09:10AM  Eli Lilly Offers Healthy Outlook to Kick Off November TheStreet.com
09:02AM  Lilly to consider more acquisitions like $1.6 billion Armo buy Reuters
08:35AM  Eli Lilly Could Hit New Highs, but Market Weakness Could Mute Gains TheStreet.com
08:32AM  Eli Lilly Earnings, Revenue beat in Q3 Investing.com
07:45AM  [$$] Eli Lilly Raises 2018 Guidance after Strong 3Q The Wall Street Journal
07:43AM  Stocks making the biggest move premarket: CVS, Eli Lilly, Marriott, Mylan & more CNBC
07:40AM  Eli Lilly (LLY) Q3 Earnings Surpass Estimates Zacks
07:40AM  Top 5 Things to Know in The Market on Tuesday Investing.com
07:16AM  Eli Lilly CEO on earnings and drug pricing CNBC Videos
07:07AM  Should You Buy Paypal Holdings Inc (PYPL)? Insider Monkey
07:00AM  Today's Research Reports on Trending Tickers: GlaxoSmithKline and Eli Lilly and Company ACCESSWIRE
06:46AM  Lilly: 3Q Earnings Snapshot Associated Press
06:41AM  Eli Lilly beats earnings expectations, raises guidance MarketWatch
06:30AM  Eli Lilly posts top and bottom line beats CNBC Videos
06:25AM  Lilly Delivers Solid Third-Quarter 2018 Results, Revises EPS Guidance PR Newswire
Nov-05-18 11:31PM  Asian shares meander, oil lower ahead of US midterms vote Associated Press
05:11PM  Berkshire Hathaway and Lilly climb; Sysco and MGM sink Associated Press
04:30PM  Lilly and NextCure Announce Collaboration to Discover and Develop Novel Immuno-Oncology Medicines PR Newswire
02:20PM  Epizyme (EPZM) Reports Narrower-Than-Expected Loss in Q3 Zacks
02:09PM  Is Eli Lilly and (LLY) Stock Outpacing Its Medical Peers This Year? Zacks
12:09PM  Eli Lilly Gets Ready For First Report Post-Elanco IPO Benzinga
11:20AM  Trulicity® (dulaglutide) demonstrates superiority in reduction of cardiovascular events for broad range of people with type 2 diabetes CNW Group
09:30AM  Is Eli Lilly and (LLY) Stock Outpacing Its Medical Peers This Year? Zacks
07:56AM  Disney, Michael Kors, Ralph Lauren and Eli Lilly are part of Zacks Earnings Preview Zacks
07:26AM  Top 5 Things to Know in The Market on Monday Investing.com
07:20AM  Lilly says diabetes drug Trulicity reduces heart risks in trial Reuters
06:45AM  Trulicity® (dulaglutide) demonstrates superiority in reduction of cardiovascular events for broad range of people with type 2 diabetes PR Newswire
06:30AM  Initial results from EMPRISE real-world evidence study show Jardiance® was associated with reduced risk for hospitalization for heart failure compared with DPP-4 inhibitors in people with type 2 diabetes with and without cardiovascular disease PR Newswire
Nov-04-18 07:39AM  Economic Calendar - Top 5 Things to Watch This Week Investing.com
Nov-02-18 06:11PM  AMAG Posts Wider-Than-Expected Q3 Loss, Beats on Revenues Zacks
08:09AM  Pharma Stock Roundup: PFE, AGN Q3 Earnings, LLY, NVS Collaboration Deals in Focus Zacks
Nov-01-18 04:50PM  Zoetis (ZTS) Beats on Q3 Earnings & Sales, Updates '18 View Zacks
12:36PM  Novo Nordisk (NVO) Q3 2018 Earnings Conference Call Transcript Motley Fool
11:14AM  United Therapeutics (UTHR) Q3 Earnings Beat but Stock Dips Zacks
10:31AM  Eli Lilly (LLY) to Report Q3 Earnings: What's in the Cards? Zacks
10:29AM  Glaxo (GSK) Beats on Q3 Earnings & Sales, Raises '18 View Zacks
09:55AM  3 Pharma Stocks to Make a Portfolio Feel Better Investopedia
05:59AM  Upbeat sales lift Novo Nordisk as drugmaker weathers U.S. pricing pressure Reuters
Oct-31-18 06:50PM  Eli Lilly (LLY) Gains But Lags Market: What You Should Know Zacks
02:52PM  The Pharmaceuticals Industry Stock Outlook: A Steady Path Ahead Zacks
Oct-30-18 02:45PM  Incyte (INCY) Misses on Q3 Earnings & Revenues, Updates View Zacks
09:22AM  Your first trade for Tuesday, Oct 30 CNBC
09:15AM  This is Why Eli Lilly (LLY) is a Great Dividend Stock Zacks
Oct-29-18 04:16PM  Biogen And Eisai May Be At Odds In Alzheimer's So What Now? Investor's Business Daily
09:31AM  Dicerna Soars After Eli Lilly Invests $100M In Licensing, Research Deal Benzinga
07:09AM  Dicerna's stock rockets after licensing, research collaboration with Eli Lilly MarketWatch
06:00AM  Lilly and Dicerna Announce RNAi Licensing and Research Collaboration PR Newswire
06:00AM  Eli Lilly makes bet on gene-silencing drug firm Dicerna Reuters
06:00AM  Drug giant Lilly backs Cambridge's Dicerna in $200M deal American City Business Journals
Oct-28-18 08:08PM  [$$] Follow the FDAs Self-Interest The Wall Street Journal
Oct-25-18 03:46PM  Eli Lilly Is Just Taking a Normal Pause TheStreet.com
09:06AM  Merck says to retain animal health business as part of company Reuters
08:00AM  Today's Research Reports on Trending Tickers: AstraZeneca and Eli Lilly and Company ACCESSWIRE
Oct-24-18 12:55PM  Pfizer Succeeds in Pain Study, Forms JV to Make CNS Drugs Zacks
07:12AM  New pain drug from Pfizer and Eli Lilly shows promise as opioid alternative MarketWatch
Oct-23-18 11:05PM  Pfizer-Lilly non-opioid drug helps reduce osteoarthritis pain Reuters
06:40PM  Pfizer-Lilly non-opioid drug helps reduce osteoarthritis pain Reuters
Eli Lilly and Company discovers, develops, manufactures, and markets pharmaceutical products worldwide. The company operates through two segments, Human Pharmaceutical Products and Animal Health Products. It offers endocrinology products for the treatment of diabetes; osteoporosis in postmenopausal women and men; and human growth hormone deficiency and pediatric growth conditions. The company also provides neuroscience products for the treatment of depressive disorder, diabetic peripheral neuropathic pain, anxiety disorder, fibromyalgia, and chronic musculoskeletal pain; schizophrenia; attention-deficit hyperactivity disorder; obsessive-compulsive disorder, bulimia nervosa, and panic disorder; and positron emission tomography imaging of beta-amyloid neurotic plaques in adult brains, as well as immunology products to treat Alzheimer's disease. In addition, it offers oncology products to treat non-small cell lung, colorectal, head and neck, pancreatic, metastatic breast, ovarian, bladder, and metastatic gastric cancers, as well as malignant pleural mesothelioma; and cardiovascular products to treat erectile dysfunction and benign prostatic hyperplasia; and migraine. Further, the company provides animal health products, such as cattle feed additives; protein supplements for cows; leanness and performance enhancers for swine and cattle; antibiotics to treat respiratory and other diseases in cattle, swine, and poultry; anticoccidial agents for poultry use; and chewable tablets that kill fleas and prevent heartworm diseases. Additionally, it offers vaccines to prevent bordetella, Lyme disease, rabies, and parvovirus. The company has collaboration agreements with Daiichi Sankyo Co., Ltd.; Incyte Corporation; Pfizer Inc.; AstraZeneca; and Nektar Therapeutics, as well as has strategic collaboration with Sigilon Therapeutics. Eli Lilly and Company was founded in 1876 and is headquartered in Indianapolis, Indiana.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
LILLY ENDOWMENT INC10% OwnerNov 13Sale113.412,460278,979118,800,804Nov 14 10:44 AM
LILLY ENDOWMENT INC10% OwnerNov 12Sale113.48202,54022,984,877118,803,264Nov 13 10:51 AM
LILLY ELI & CO10% OwnerNov 06Sale14.00700,0009,800,0003,148,647Nov 08 11:34 AM
Norton JohnaSenior VP, Global QualityNov 03Option Exercise0.003,133019,225Nov 06 01:25 PM
LILLY ENDOWMENT INC10% OwnerOct 17Sale113.25174,69619,783,623119,005,804Oct 18 02:26 PM
LILLY ENDOWMENT INC10% OwnerOct 09Sale115.9110,6721,237,013119,180,500Oct 10 01:17 PM
LILLY ENDOWMENT INC10% OwnerOct 08Sale115.9114,6321,696,039119,191,172Oct 09 01:14 PM
LILLY ENDOWMENT INC10% OwnerOct 04Sale112.67116,03813,073,950119,205,804Oct 05 02:47 PM
Zulueta Alfonso GSVP & President, Lilly Int'lOct 04Sale114.647,000802,48045,224Oct 05 02:08 PM
LILLY ENDOWMENT INC10% OwnerOct 03Sale109.0178,9628,607,253119,321,842Oct 04 02:29 PM
LILLY ENDOWMENT INC10% OwnerSep 28Sale107.31107,55311,541,082119,400,804Oct 01 11:53 AM
LILLY ENDOWMENT INC10% OwnerSep 27Sale107.0092,4479,891,644119,508,357Sep 28 10:36 AM
LILLY ENDOWMENT INC10% OwnerSep 26Sale106.63134,41014,332,373119,600,804Sep 27 12:26 PM
LILLY ENDOWMENT INC10% OwnerSep 25Sale106.4155,5905,915,165119,735,214Sep 26 01:49 PM
LILLY ELI & CO10% OwnerSep 24Sale16.362,02733,1623,848,647Sep 26 02:50 PM
LILLY ELI & CO10% OwnerSep 18Sale14.566,870100,0273,850,674Sep 20 04:50 PM
Zulueta Alfonso GSVP & President, Lilly Int'lSep 18Sale107.003,000321,00052,224Sep 19 05:47 PM
LILLY ELI & CO10% OwnerSep 17Sale14.586,865100,0923,857,544Sep 18 07:30 PM
Zulueta Alfonso GSVP & President, Lilly Int'lSep 17Sale105.613,000316,83055,224Sep 19 05:47 PM
LILLY ELI & CO10% OwnerSep 14Sale14.589,009131,3513,864,409Sep 18 07:30 PM
LILLY ELI & CO10% OwnerSep 13Sale14.3220,900299,2883,873,418Sep 14 03:34 PM
LILLY ELI & CO10% OwnerSep 12Sale14.8310,059149,1753,894,318Sep 14 03:34 PM
LILLY ELI & CO10% OwnerSep 11Sale14.8711,277167,6893,904,377Sep 12 04:39 PM
LILLY ELI & CO10% OwnerSep 10Sale14.444,50064,9803,915,654Sep 12 04:39 PM
LILLY ENDOWMENT INC10% OwnerSep 07Sale106.76180,00019,217,055119,790,804Sep 10 12:44 PM
Zakrowski Donald AChief Accounting OfficerSep 04Sale105.5760063,3423,530Sep 04 04:50 PM
LILLY ELI & CO10% OwnerAug 31Sale14.267009,9823,920,154Sep 04 03:38 PM
LILLY ELI & CO10% OwnerAug 30Sale14.353,44049,3643,920,854Aug 31 12:40 PM
LILLY ENDOWMENT INC10% OwnerAug 30Sale105.42190,00020,030,370119,970,804Aug 31 09:07 AM
LILLY ELI & CO10% OwnerAug 29Sale14.262,31232,9693,924,294Aug 31 12:40 PM
LILLY ENDOWMENT INC10% OwnerAug 20Sale105.89195,00020,647,575120,160,804Aug 21 02:12 PM
LILLY ENDOWMENT INC10% OwnerAug 16Sale104.50200,00020,899,800120,355,804Aug 17 03:08 PM
LILLY ENDOWMENT INC10% OwnerAug 15Sale103.23151,79315,669,440120,555,804Aug 16 02:52 PM
LILLY ELI & CO10% OwnerAug 14Sale14.283,00042,8403,926,606Aug 16 03:34 PM
LILLY ELI & CO10% OwnerAug 13Sale14.334,53164,9293,929,606Aug 14 05:04 PM
LILLY ELI & CO10% OwnerAug 10Sale14.281,89827,1033,934,137Aug 14 05:04 PM
LILLY ENDOWMENT INC10% OwnerAug 10Sale103.063,587369,676120,707,597Aug 13 03:41 PM
LILLY ENDOWMENT INC10% OwnerAug 07Sale103.2224,6202,541,326120,711,184Aug 08 01:28 PM
LILLY ENDOWMENT INC10% OwnerAug 06Sale102.15195,00019,918,860120,735,804Aug 07 11:46 AM
LILLY ELI & CO10% OwnerAug 03Sale13.551,65022,3583,936,035Aug 07 03:16 PM
LILLY ELI & CO10% OwnerAug 02Sale13.3119,400258,2143,937,685Aug 03 03:53 PM
LILLY ENDOWMENT INC10% OwnerAug 02Sale99.58190,00018,919,939120,930,804Aug 03 02:31 PM
LILLY ENDOWMENT INC10% OwnerJul 31Sale98.74205,00020,240,873121,120,804Aug 01 01:12 PM
TAI JACKSON PDirectorJul 26Buy95.222,168206,43753,228Jul 27 10:46 AM
LILLY ENDOWMENT INC10% OwnerJul 25Sale94.73190,00017,999,259121,325,804Jul 26 02:17 PM
LILLY ENDOWMENT INC10% OwnerJul 24Sale92.03185,00017,025,985121,515,804Jul 25 11:47 AM
LILLY ENDOWMENT INC10% OwnerJul 06Sale87.44180,00015,738,300121,700,804Jul 09 10:45 AM
Pusey Leigh AnnSVP, Corp. Affairs & Comm.Jul 05Option Exercise0.002,39402,394Jul 09 11:58 AM
LILLY ENDOWMENT INC10% OwnerJul 05Sale86.62170,00014,725,740121,880,804Jul 06 11:13 AM
LILLY ENDOWMENT INC10% OwnerJun 15Sale86.65180,00015,597,720122,050,804Jun 18 12:39 PM
Skovronsky DanielSVP, CSO, and Pres. LRLJun 14Buy86.2210,000862,20055,199Jun 14 04:08 PM
LILLY ENDOWMENT INC10% OwnerJun 14Sale86.31107,6989,295,414122,230,804Jun 15 11:00 AM
LILLY ENDOWMENT INC10% OwnerJun 13Sale86.2711,104957,953122,338,502Jun 14 11:58 AM
LILLY ENDOWMENT INC10% OwnerJun 11Sale86.3851,1984,422,637122,349,606Jun 12 02:46 PM
LILLY ENDOWMENT INC10% OwnerJun 04Sale85.13135,47811,532,565122,400,804Jun 05 11:20 AM
LILLY ENDOWMENT INC10% OwnerJun 01Sale85.3139,5223,371,661122,536,282Jun 04 02:25 PM
Conterno Enrique ASVP&Pres, LillyDiab & LillyUSAMay 31Sale85.0025,0002,125,000124,534Jun 01 04:22 PM
LILLY ENDOWMENT INC10% OwnerMay 30Sale83.85180,00015,092,640122,575,804May 31 01:18 PM
Shaw ChristiSVP and Pres., Lilly Bio-MedsMay 29Sale82.108,426691,7750May 31 01:05 PM
LILLY ENDOWMENT INC10% OwnerMay 11Sale81.97140,00011,475,940122,755,804May 14 02:29 PM
Simmons Jeffrey NSVP&Pres. Elanco Animal HealthMay 03Sale78.509,027708,620135,458May 03 04:34 PM
Simmons Jeffrey NSVP&Pres. Elanco Animal HealthMay 01Option Exercise0.0020,0000153,201May 03 04:34 PM
Shaw ChristiSVP and Pres., Lilly Bio-MedsMay 01Option Exercise0.0013,750013,750May 03 04:29 PM
Conterno Enrique ASVP&Pres, LillyDiab & LillyUSAMay 01Option Exercise0.0020,0000158,468May 03 04:26 PM
LILLY ENDOWMENT INC10% OwnerApr 25Sale80.85180,00014,553,614122,895,804Apr 26 12:38 PM
Mahony SusanSVP & Pres., Lilly OncologyApr 16Sale80.0817,3791,391,71028,273Apr 17 03:29 PM
Mahony SusanSVP & Pres., Lilly OncologyApr 13Sale80.145,165413,92345,652Apr 17 03:29 PM
Smiley Joshua LSVP and CFOMar 16Sale79.203,000237,60020,029Mar 20 12:06 PM
Zakrowski Donald AChief Accounting OfficerMar 01Sale76.5086065,7901,637Mar 05 03:30 PM
Zakrowski Donald AChief Accounting OfficerFeb 21Sale77.5587667,9342,472Feb 23 05:42 PM
Norton JohnaSenior VP, Global QualityFeb 16Option Exercise0.0048048Feb 21 10:28 AM
Zakrowski Donald AChief Accounting OfficerFeb 05Sale81.0990072,9814,130Feb 05 06:39 PM
Simmons Jeffrey NSVP&Pres. Elanco Animal HealthFeb 05Sale81.129,625780,780133,201Feb 05 06:37 PM
O'Neill MylesSVP & Pres., Mfg. OperationsFeb 01Option Exercise0.009,596080,234Sep 24 04:45 PM
Simmons Jeffrey NSVP&Pres. Elanco Animal HealthFeb 01Option Exercise0.0021,3260152,120Feb 05 06:37 PM
Zulueta Alfonso GSVP & President, Lilly Int'lFeb 01Option Exercise0.0015,993065,357Feb 05 06:33 PM
Ricks David APresident & CEOFeb 01Option Exercise0.0021,3260140,809Feb 05 06:31 PM
Mahony SusanSVP & Pres., Lilly OncologyFeb 01Option Exercise0.0021,326060,350Feb 05 06:24 PM
Lundberg Jan MEVP,Science&Tech and Pres. LRLFeb 01Option Exercise0.0036,2520214,295Feb 05 06:21 PM
Harrington Michael JSenior VP and General CounselFeb 01Option Exercise0.0024,5240102,738Feb 05 06:19 PM
Fry Stephen FSVP, HR & DiversityFeb 01Option Exercise0.0017,0600107,820Feb 05 06:15 PM
Conterno Enrique ASVP&Pres, LillyDiab & LillyUSAFeb 01Option Exercise0.0021,3260147,980Feb 05 06:12 PM
Barnes Melissa SChief Eth/Cmpl Ofcr & SVP, ERMFeb 01Option Exercise0.006,398022,107Feb 05 06:09 PM
LILLY ENDOWMENT INC10% OwnerDec 13Sale88.20200,00017,639,176123,075,804Dec 14 11:26 AM
Simmons Jeffrey NSVP&Pres. Elanco Animal HealthDec 11Sale86.4612,5001,080,750124,522Dec 13 03:01 PM
Zulueta Alfonso GSVP & President, Lilly Int'lDec 04Sale86.003,532303,75240,048Dec 05 05:35 PM
Mahony SusanSVP & Pres., Lilly OncologyDec 04Sale86.1836,5853,152,89554,885Dec 05 05:32 PM
Zakrowski Donald AChief Accounting OfficerDec 03Option Exercise0.003,28104,167Dec 05 05:48 PM
Fry Stephen FSVP, HR & DiversityDec 03Option Exercise0.007,557086,501Dec 05 05:46 PM
Ricks David APresident & CEODec 03Option Exercise0.005,4960110,059Dec 05 05:43 PM